Report copyright - Engineering the Medicines of Tomorrow...ICML 2019 #124, Salles et al, L-MIND –June 22, 2019 5 Safety Profile of Tafasitamab + LEN N=81. TEAEs, treatment-emergent adverse events,
Please pass captcha verification before submit form
Please pass captcha verification before submit form